Search Results for: neuroblastoma

Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma

Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients’ T cells so they can …Read More

Call it mother’s intuition, but leading up to her daughter’s cancer diagnosis, Erica Jensen knew something wasn’t right. At just …Read More

Neuroblastoma is a rare childhood cancer affecting about 800 children each year in the United States. Because of its unusual …Read More

Since the early 1990s, chemotherapy followed by an autologous stem cell transplant has been the standard of care for high-risk …Read More

The Downey family was enjoying the holidays with family in Guatemala in 2017 when their 13-month-old daughter Stella started having …Read More

Neuroblastoma and other children’s cancers pose unique challenges. They’re not caused by the same kinds of genetic mutations that cause …Read More

Cancer and other diseases are now understood to spring from a complex interplay of biological factors rather than any one …Read More

When Emily Coughlin complained of a sore knee in May 2009, doctors initially suspected Lyme disease. After antibiotics failed to …Read More

Dr. Marla Lipsyc-Sharf is no stranger to the field of medicine: As a medical oncology fellow, she’s familiar with the …Read More

Thanks to developments in precision medicine, some adult cancers are now treated with designer drugs that target the genetic mutations …Read More